Offer - Urjas Oil for just ₹ 1 X
Atorvastatin + Telmisartan is an allopathic medicine The correct dosage of Atorvastatin + Telmisartan depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Atorvastatin + Telmisartan is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Atorvastatin + Telmisartan is used -
Severe
Moderate
Mild
Common
Is the use of Atorvastatin + Telmisartan safe for pregnant women?
Pregnant women may get severe side effects after taking Atorvastatin + Telmisartan. If you are pregnant, do not take Atorvastatin + Telmisartan without a doctor's advice.
Is the use of Atorvastatin + Telmisartan safe during breastfeeding?
Atorvastatin + Telmisartan has been seen to have minimal side effects on breastfeeding women.
What is the effect of Atorvastatin + Telmisartan on the Kidneys?
Atorvastatin + Telmisartan is completely safe for kidneys.
What is the effect of Atorvastatin + Telmisartan on the Liver?
Very few cases of side effects of Atorvastatin + Telmisartan on the liver have been reported.
What is the effect of Atorvastatin + Telmisartan on the Heart?
Atorvastatin + Telmisartan may have mild side effects on the heart. Most people will never see any effect on the heart.
Atorvastatin + Telmisartan should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Atorvastatin + Telmisartan unless your doctor advises you to do so -
Is this Atorvastatin + Telmisartan habit forming or addictive?
Atorvastatin + Telmisartan is not addictive in nature.
Interaction between Food and Atorvastatin + Telmisartan
Eating certain foods may increase the time it takes Atorvastatin + Telmisartan to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Atorvastatin + Telmisartan
Taking alcohol with Atorvastatin + Telmisartan can be dangerous.
No, Atorvastatin + Telmisartan should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Atorvastatin + Telmisartan can be taken in the morning. It can be taken anytime once in a day with food or without food or as advised by your doctor.
Atorvastatin + Telmisartan works by inhibiting an enzyme (HMG-CoA reductase) which is responsible for cholesterol synthesis in our body, its inhibition results in increased levels of HDL (good cholesterol) and decreased levels of LDL (bad cholesterol) which lowers the risk of developing heart disease and helps in preventing strokes
No, Atorvastatin + Telmisartan does not cause diabetes. It has not been reported to cause diabetes. However, Atorvastatin + Telmisartan might increase your blood sugar levels slightly. So, if you have diabetes keep a check on your blood sugar levels and in case of a sudden spike inform your doctor and take medicines accordingly.
Yes, Atorvastatin + Telmisartan might cause hair loss but it occurs very rarely. This problem goes away after discontinuation of the drug. However, if you notice excessive hair loss then consult it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)